Facebook
Linkedin
Pinterest
Reddit
Twitter
Medical Devices
Biotechnology
Clinical Trials
Mergers & Acquisitions
Funding
FDA
Industry Expert Articles
Other News
Market Reports
Executives
Hospitals
Imaging
Ultrasound
Health
Articles
Search
MDT InterStim
FDA Approves Expanded Labeling of MDT InterStim
FDA has expanded MRI labeling of its InterStim™ II and InterStim™ Micro sacral neuromodulation (SNM) systems that use SureScan™ MRI leads, reports Medtronic.
February 18, 2021
Exit mobile version